Charlottesville Medical Research
Charlottesville, Virginia 22911
6 studies enrolling now · 82 studies all time
What they study most
Alzheimer Disease, Arthritis, Bilateral Nasolabial Fold Wrinkles, Binge Eating Disorder, Bowel Preparation, COVID-19, COVID-19 (Coronavirus Disease 2019), Central Abdominal Bulging, Chronic Anal Fissures, Chronic Constipation, Colon Cancer, Colonic Diseases
Studies at this site
- Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight — Recruiting now
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee — Recruiting now
- A Study of Dotinurad Versus Allopurinol in Tophaceous Gout — Recruiting now
- A Study of Dotinurad Versus Allopurinol in Participants With Gout — Recruiting now
- A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia — Recruiting now
- A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine — Recruiting now
- A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation — Running, not enrolling
- A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity — Running, not enrolling
- A Study About Modified RNA Vaccines Against Influenza in Healthy Adults — Completed
- A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
- A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years — Completed
- Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode — Running, not enrolling
- A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age — Running, not enrolling
- Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis — Stopped early
- Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) — Running, not enrolling
- A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity — Running, not enrolling
- Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine — Completed
- A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People — Completed
- A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen — Completed
- Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo — Running, not enrolling
- A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults — Completed
- A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes — Completed
- A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People — Completed
- A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease — Completed
- Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults — Completed
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza — Completed
- A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — Completed
- A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833 — Completed
- A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause — Completed
- Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults — Completed
- Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults — Completed
- Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis — Stopped early
- A Safety Study of 3 Different Bowel Cleansing Preparations — Completed
- A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine — Completed
- A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine — Completed
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine — Completed
- Trial in Adult Subjects With Acute Migraines — Completed
- Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine — Completed
- Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine — Completed
- Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis — Completed
- 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine — Completed
- A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
- Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder — Completed
- Open Label Extension in Adults With Binge Eating Disorder (BED) — Completed
- Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease — Completed
- Extension Study Of Tanezumab In Osteoarthritis — Stopped early
- Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study — Stopped early
- Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
- Tanezumab in Osteoarthritis of the Knee — Completed
- Tanezumab in Osteoarthritis Of The Hip — Completed